(Q86165327)

English

Development of Next-Generation Immunomodulatory Antibodies for Cancer Therapy through Optimization of the IgG Framework

scientific article published on 01 September 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

title

Development of Next-Generation Immunomodulatory Antibodies for Cancer Therapy through Optimization of the IgG Framework (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

author name string

Rienk Offringa

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

Martin J Glennie

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

publication date

1 September 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

volume

28

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

page(s)

273-275

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

Identifiers

DOI

10.1016/J.CCELL.2015.08.008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

retrieved

24 February 2020

PubMed publication ID

26373272

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26373272

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26373272%20AND%20SRC:MED&resulttype=core&format=json

(Q86165327)

Development of Next-Generation Immunomodulatory Antibodies for Cancer Therapy through Optimization of the IgG Framework

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)